Adrienne Terico, Pharm.D. is the 2013-14 Temple ID resident. She graduated from Temple University and completed her PGY-1 Pharmacy Residency at Temple University Hospital. Her project is evaluating outcomes in patients with methicillin-susceptible Staphylococcus aureus bacteremia whose empiric antibiotic regimen contained a beta-lactam compared to those whose regimen did not.
Elizabeth Marino, Pharm.D., BCPS was the program's first resident during 2008-9. Liz graduated from Temple University School of Pharmacy and completed her Pharmacy Practice Residency at Temple University Health System. Her grant-funded project was an investigation into the impact of the reporting on ESBL-production in Klebsiella pneumoniae on practitioner selection of antimicrobials. Liz is currently the Clinical Pharmacist Specialist, Infectious Diseases at Pennsylvania Hospital in Philadelphia.
Jenna Ferrara, Pharm.D., BCPS was the ID resident at Temple during 2009-10. She graduated from Temple University School of Pharmacy and completed her Pharmacy Practice Residency at Allegheny General Hospital in Pittsburgh, PA. Her project investigated the role of appropriate empiric pharmacotherapy on outcomes in bacteremia caused by Gram-negative organisms. Jenna is currently in independent pharmacy practice in Georgia and studying for a Master's of Public Health degree. She was previously an Assistant Professor at PCOM School of Pharmacy in Georgia.
Thy Le, Pharm.D. was the 2010-11 ID resident. She graduated from Wingate University and completed her Pharmacy Practice Residency at the Brooklyn Hospital Center. Her project evaluated the impact of the time to appropriate therapy on outcomes in candidemia. She is currently an infectious diseases pharmacist at Coney Island Hospital in Brooklyn.
Safia Kuriakose, Pharm.D. was the 2011-12 ID resident. She graduated from the University of Pittsburgh and completed her Pharmacy Practice Residency at Baystate Medical Center in Springfield, Massachusetts. Her grant-funded project evaluated and compared risk factors for carbapenem-resistant and third-generation cephalosporin-resistant Klebsiella bacteremia. She is currently an infectious diseases pharmacist at St. Joseph’s Regional Medical Center in New Jersey.
Kimberly Toussaint, Pharm.D., BCPS was the 2012-13 ID resident. She graduated from the Temple University and completed her PGY-1 Pharmacy Residency at the University of Maryland Medical Center in Baltimore. Her project explored the legitimacy of risk factors for health-care associated pneumonia and how they drive antibiotic choices. She is currently a Clinical Assistant Professor at Temple University School of Pharmacy in HIV medicine.